The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Clinical and molecular hepatology

Volumn 22, Issue 3, 2016, Pages 319-326

  Varbobitis, Ioannis ^a   Papatheodoridis, George V ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antivirals; Hepatitis B; Hepatocellular carcinoma; Interferon alfa

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; NUCLEOTIDE;

CARCINOMA, HEPATOCELLULAR; CHEMISTRY; COMPLICATION; HEPATITIS B, CHRONIC; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; RISK FACTOR;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER NEOPLASMS; NUCLEOTIDES; RISK FACTORS;

EID: 85050579969     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2016.0045     Document Type: Review

References (0)